Related Experiment Video
Updated: Jul 6, 2026

A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence
Published on: May 26, 2023
The quest to conquer age-related macular degeneration
1Warren Alpert Medical School, Brown University, Providence, RI, USA. rgbryan@alumni.duke.edu
Abstract:
AMD causes irreversible blindness in the elderly. For years, treatment has been non-existent or ineffective. With the advent of anti-VEGF agents, ophthalmologists can stabilize and even improve visual function in these patients. To accomplish this, however, requires frequent intraocular injections and follow-up, costly in time and money to the patient and the health-care system. In the near future, it is likely that newer strategies and newer drugs will make the treatment of AMD easier, more effective, and more affordable.
More Related Videos
10:14Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
06:16LipidUNet-Machine Learning-Based Method of Characterization and Quantification of Lipid Deposits Using iPSC-Derived Retinal Pigment Epithelium
Published on: July 28, 2023
Related Concept Videos
Diabetic Retinopathy
iPS Cell Differentiation
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Photoreceptors and Visual Pathways